So the UKCMRI partners were in front of the House of Commons Science and Technology Committee yesterday as were representatives of the local community. Meanwhile the Science Minister, David Willetts, announced that the Government had agreed the business plan for the new centre as put forward by the Medical Research Council (MRC). A good day all … Continue reading UKCMRI Task Gets Bigger
biotechs
Pfizer…and innovation emergencies
The news that Pfizer is to close its R&D facility in Sandwich in Kent has shaken us from our sleepy winter hollows. I've been watching the reactions and comments come over the wires as I am sure you have. This is clearly a company going through considerable transition as it tries to change with the … Continue reading Pfizer…and innovation emergencies
An evening of industry – how the pharma business model is changing
So it's 10pm and I'm busy here putting the final touches to the AMRC/INVOLVE report of the workshop we held in November which drew together patient views on health research regulation. This was at the invitation of the Academy of Medical Sciences as part of their review of regulation and governance but - and all … Continue reading An evening of industry – how the pharma business model is changing
When good medicine is the casualty of hype and ignorance
I have just returned from the Financial Times' offices, where I was the guest for their regular science podcast hosted by Clive Cookson and Andrew Jack (it will appear here later today). The theme of the discussion was 'Selling Sickness.' Andrew was reporting on a recent conference of the same name that took place last month in Holland. … Continue reading When good medicine is the casualty of hype and ignorance
Capability Dave announces cluster therapy for research
Monday saw the Science Mnister, David Willetts, and Health Minister, Earl Howe, announce what are being called therapeutic capability clusters (research consortia) at the ABPI/BIA conference in London. PharmaLetter has an article on it and what I think is the formal news release can be found on Pharma Live. Don't be fooled by the PR … Continue reading Capability Dave announces cluster therapy for research
Science at the Conservative Party Conference – avoiding the herd mentality
I read in the Birmingham local press that about 14,000 people are expected at the Conservative Party Conference. It certainly seems busier than the preceding two, even on a Sunday evening. Each conference has its own feel but common to them all is the herd of grey-suited buffalo (including myself I suppose) that migrates from one … Continue reading Science at the Conservative Party Conference – avoiding the herd mentality
Science at the Labour Party Conference – Ed captures hearts but not science
In my potter around the conference exhibition this afternoon, I stumbled upon a stand for the 'People's Museum' here in Manchester which charts the struggles of the working class and houses the Labour Party's official archives. I wish I had time to pop along if only to check whether my knowledge of political history is … Continue reading Science at the Labour Party Conference – Ed captures hearts but not science
Science at the Labour Party Conference – a Miller's tale
Rumour has it that there is an outbreak of tonsilitis in the north-west at the moment...here's hoping Ed Milliband is being kept in isolation until his leader's speech this afternoon. One thing I forgot to mention from last night's meeting was David Lammy's comment that the coalition government has yet to put together a convincing narrative for … Continue reading Science at the Labour Party Conference – a Miller's tale
Science at the Lib Dem Conference – Life Sciences Breakfast
Policy-making is not immune to trends. The latest seems to be the 'roundtable' meeting. I blame King Arthur myself (well, they say that trends do come round). But I bet he didn't meet his knights at 9 or 8am. This morning AMRC, the BioIndustry Association, Association of British Healthcare Industries and Association of the British … Continue reading Science at the Lib Dem Conference – Life Sciences Breakfast
Venture capitalists weigh in on science funding debate
I spoke at an interesting event last week organised by OneNucleus, a membership organisation which brings together international life science and healthcare companies. The audience was packed with representatives of both large and small companies including many biotechs. It was the day before Vince Cable's speech and much concern about what he would or would not … Continue reading Venture capitalists weigh in on science funding debate
Simon Denegri's Lay Review 